Luis Eduardo M. Quintas

Universidade Federal do Rio de Janeiro

Papers

1

Total Citations

8

H-Index

1

About

Luis Eduardo M. Quintas is a leading pharmacologist whose research focuses on the molecular mechanisms of drug action, with particular emphasis on radioligand binding assays and their critical role in the drug discovery pipeline. His most cited work, "Radioligand Binding Assays in the Drug Discovery Process: Potential Pitfalls of High Throughput Screenings" (2011), has garnered 8 citations and stands as a seminal contribution to the field. In this paper, Quintas systematically identifies the experimental simplifications inherent in high-throughput screening that can compromise assay reliability, offering a rigorous framework for minimizing false positives and false negatives. His insights have proven invaluable for researchers designing binding assays to evaluate drug-target interactions, directly impacting the efficiency of early-stage drug development. Beyond this landmark study, Quintas has advanced understanding of receptor pharmacology and the pharmacokinetic principles governing drug behavior. His work is characterized by a meticulous attention to experimental design, making him a trusted authority for students and scientists navigating the complexities of drug discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Radioligand Binding Assays in the Drug Discovery Process: Potential Pitfalls of High Throughput Screenings
8 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Universidade Federal do Rio de Janeiro

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago